Results 71 to 80 of about 11,258 (167)

Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases

open access: yes, 2016
B Acute Lymphoblastic leukemia (B-ALL) with Philadelphia chromosome (Ph') is a neoplasm of lymphoblast committed to the B cell lineage. The clinical presentation of B-ALL Ph'+ is similar to B-ALL, but is more common in adults than in children. The e1a3 rare variant is produced by the fusion of BCR exon 1 to ABL exon 3.
Lopez-Andrade, Bernardo   +12 more
openaire   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses.

open access: yesHaematologica, 2006
Chronic myelogenous leukemia (CML) presents a unique opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also the oncogenic protein required for neoplasia. We have shown in phase I and II trials that a tumor-specific, bcr-abl-derived peptide vaccine can be safely administered to patients with ...
Javier, Pinilla-Ibarz   +4 more
openaire   +1 more source

Non-receptor tyrosine kinase signaling pathways and therapeutic implications. [PDF]

open access: yesSignal Transduct Target Ther
Hossain MDA   +4 more
europepmc   +1 more source

Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis. [PDF]

open access: yesACS Cent Sci
Merz ML   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy